Company Filing History:
Years Active: 2009-2010
Title: Michelle Akerman: Innovator in Pharmaceutical Compositions
Introduction
Michelle Akerman is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of metabolic disorders. With a total of 3 patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
Among her latest patents, one notable invention focuses on compounds, pharmaceutical compositions, and methods for use in treating metabolic disorders. This invention provides compounds that are useful for modulating insulin levels in a subject, characterized by the general formula Q-L-P-L-M-X-L-A. The definitions of the variables Q, L, P, L, M, X, L, and A are detailed within the patent. This invention also outlines compositions and methods for utilizing these compounds, particularly for the treatment of type II diabetes.
Career Highlights
Michelle Akerman is currently employed at Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to explore innovative solutions in the pharmaceutical industry. Her dedication to research and development has positioned her as a key player in her field.
Collaborations
Throughout her career, Michelle has collaborated with notable colleagues, including Jonathan B. Houze and Jiwen Liu. These collaborations have further enhanced her research and contributed to the success of her inventions.
Conclusion
Michelle Akerman's contributions to pharmaceutical innovations are noteworthy and impactful. Her work continues to influence the treatment of metabolic disorders, showcasing her commitment to advancing medical science.